Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

NCT03177018 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03177018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03177018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
September 13, 2016
Completion date
December 31, 2018
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia